Jennifer Dorth
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (NCT07425054) | Jennifer Dorth | 2026-06-19 |
Track Jennifer Dorth automatically
Every clearance here is in the API, with alerts when new ones post.